125 related articles for article (PubMed ID: 1331447)
21. Inhibition of 3H-leukotriene D4 binding to guinea pig lung receptors by the novel leukotriene antagonist ICI 198,615.
Aharony D; Falcone RC; Krell RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):921-6. PubMed ID: 2826761
[TBL] [Abstract][Full Text] [Related]
22. Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine.
Liu S; Hu HZ; Gao C; Gao N; Wang G; Wang X; Gao X; Xia Y; Wood JD
Eur J Pharmacol; 2003 Jan; 459(1):27-39. PubMed ID: 12505531
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
Margolskee DJ
Ann N Y Acad Sci; 1991; 629():148-56. PubMed ID: 1659276
[No Abstract] [Full Text] [Related]
24. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
[TBL] [Abstract][Full Text] [Related]
25. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity.
Huang FC; Galemmo RA; Johnson WH; Poli GB; Morrissette MM; Mencel JJ; Warus JD; Campbell HF; Nuss GW; Carnathan GW
J Med Chem; 1990 Apr; 33(4):1194-200. PubMed ID: 2157010
[TBL] [Abstract][Full Text] [Related]
26. Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonists.
Harper RW; Herron DK; Bollinger NG; Sawyer JS; Baldwin RF; Roman CR; Rinkema LE; Fleisch JH
J Med Chem; 1992 Apr; 35(7):1191-200. PubMed ID: 1313876
[TBL] [Abstract][Full Text] [Related]
27. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
Mong S; Wu HL; Miller J; Hall RF; Gleason JG; Crooke ST
Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
Musser JH; Kubrak DM; Chang J; Lewis AJ
J Med Chem; 1986 Aug; 29(8):1429-35. PubMed ID: 3090264
[TBL] [Abstract][Full Text] [Related]
29. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
Aharony D; Catanese CA; Falcone RC
J Pharmacol Exp Ther; 1989 Feb; 248(2):581-8. PubMed ID: 2537402
[TBL] [Abstract][Full Text] [Related]
30. The pharmacology of LY290324 in the guinea-pig: an orally active, potent and selective cysteinyl leukotriene receptor antagonist.
Boot JR; Bond A; Thomas KH; O'Brien A; Gilmore J; Todd A
Eur J Pharmacol; 1993 Jan; 231(1):83-9. PubMed ID: 8383064
[TBL] [Abstract][Full Text] [Related]
31. The antinociceptive effect of leukotriene D(4) receptor antagonist, MK-571, in mice: possible involvement of opioidergic mechanism.
Gök S; Onal A; Cinar MG; Evinç A
Eur J Pharmacol; 1999 Dec; 386(2-3):195-200. PubMed ID: 10618470
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class.
von Sprecher A; Gerspacher M; Beck A; Kimmel S; Wiestner H; Anderson GP; Niederhauser U; Subramanian N; Bray MA
Bioorg Med Chem Lett; 1998 Apr; 8(8):965-70. PubMed ID: 9871521
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
[TBL] [Abstract][Full Text] [Related]
34. Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma.
Giembycz MA; Diamond J; Rodger IW
Br J Pharmacol; 1993 Mar; 108(3):824-32. PubMed ID: 8385538
[TBL] [Abstract][Full Text] [Related]
35. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations.
Cheng JB; Lang D; Bewtra A; Townley RG
J Pharmacol Exp Ther; 1985 Jan; 232(1):80-7. PubMed ID: 2981321
[TBL] [Abstract][Full Text] [Related]
36. Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig.
Foster A; Chan CC
Int Arch Allergy Appl Immunol; 1991; 96(3):279-84. PubMed ID: 1666630
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationship studies of a series of 5-aryl-4,6-dithianonanedioic acids and related compounds: a novel class of leukotriene antagonists.
Perchonock CD; Uzinskas I; McCarthy ME; Erhard KF; Gleason JG; Wasserman MA; Muccitelli RM; DeVan JF; Tucker SS; Vickery LM
J Med Chem; 1986 Aug; 29(8):1442-52. PubMed ID: 3016267
[TBL] [Abstract][Full Text] [Related]
38. Eosinophil-eicosanoid interactions: inhibition of eosinophil chemotaxis in vivo by a LTD4-receptor antagonist.
Chan CC; McKee K; Tagari P; Chee P; Ford-Hutchinson A
Eur J Pharmacol; 1990 Dec; 191(3):273-80. PubMed ID: 1964905
[TBL] [Abstract][Full Text] [Related]
39. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist.
Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; Brown FJ
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):978-87. PubMed ID: 2158259
[TBL] [Abstract][Full Text] [Related]
40. Post soluble binding to the leukotriene D4 receptor from guinea pig lung membranes.
Mong S; Sarau HM
Mol Pharmacol; 1990 Jan; 37(1):60-4. PubMed ID: 2153909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
